Federal Register: December 31, 2007 (Volume 72, Number 249)
DOCID: fr31de07-75 FR Doc E7-25329
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
DOCID: fr31de07-75
ACTION: Applications, hearings, determinations, etc.:
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Application
DOCUMENT SUMMARY:
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 10, 2007, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oripavine (9330), a basic class of controlled substance listed in schedule II.
The company plans to manufacture the listed controlled substance in bulk for sale to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substance may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a). Any such comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537; or any being sent via
express mail should be sent to the Drug Enforcement Administration,
Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than February 29, 2008.
Dated: December 20, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E725329 Filed 122807; 8:45 am]
BILLING CODE 441009P
SUMMARY:
Chattem Chemicals, Inc.,
DOCUMENT BODY 2:
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on December 10, 2007, Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by letter to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Oripavine (9330), a basic class of controlled substance listed in schedule II.
The company plans to manufacture the listed controlled substance in bulk for sale to its customers.
Any other such applicant and any person who is presently registered
with DEA to manufacture such substance may file comments or objections
to the issuance of the proposed registration pursuant to 21 CFR
1301.33(a). Any such comments or objections being sent via regular mail
should be addressed, in quintuplicate, to the Drug Enforcement
Administration, Office of Diversion Control, Federal Register
Representative (ODL), Washington, DC 20537; or any being sent via
express mail should be sent to the Drug Enforcement Administration,
Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than February 29, 2008.
Dated: December 20, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E725329 Filed 122807; 8:45 am]
BILLING CODE 441009P